ClinicalTrials.gg
CompletedNCT07554664Updated Oct 1, 2026

Central Sensitization, Work-Related Stress, and Musculoskeletal Symptoms in Desk-Based Workers With and Without Migraine

An observational study in Migraine, Worker Health and Sensitization, sponsored by Bozok University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Bozok University · Observational

How we know

Updated Oct 1, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
228
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 92 studies in Migraine Disorders with a site in Turkey — 20 open to participants now, 25 under way, 3 of them phase 3. Migraine Disorders · Turkey.

Enrollment
6th of 23
228 · median 130
Started
2026
with 8 others
Observational
23 of 92
4 open now
Registered
86th of 92
by date
Lead sponsor
4 of 92
Bozok University

Among the 92 studies in Migraine Disorders with a site in Turkey, this one is the 6th largest by enrollment of the 23 observational ones that give a count, is one of 9 that started in 2026, is one of 23 observational ones, and was the 86th registered.

Migraine Disorders

1,660 studies on the registry are indexed under Migraine Disorders; 340 are open to participants now.

Browse Migraine Disorders studies →

Open to participants now

20 of the 92 studies in Migraine Disorders with a site in Turkey are open now. Recruiting first, the newest first:

15 more — sign in →

All 20 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 217 Migraine Disorders studies recruiting now, 66 (30%) set no upper age limit and 136 (63%) stop at 75 or younger; 44 take children under 18; 37 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 92 studies in Migraine Disorders with a site in Turkey, or all of them as a file.
02

Study summary

Migraine is a common neurological disease causing significant disability worldwide, with an estimated global prevalence of 14.4%. It represents a significant individual and societal burden, particularly for working-age individuals, as it can significantly impact work performance, productivity, and daily living activities. Migraine is not merely a headache; it is characterized by increased excitability of neurons in the central nervous system, leading to hypersensitivity to pain. Central sensory mechanisms are thought to play a role in the pathophysiology and chronicity of migraine, causing increased pain sensitivity, allodynia, and potentially related to musculoskeletal pain. Furthermore, psychosocial factors and work stress have been identified as significant factors associated with both headaches and musculoskeletal pain. Literature indicates that neck pain is common in individuals with migraine headaches; in fact, neck pain is twice as frequent in patients with chronic migraine headaches compared to those with episodic migraine. While evidence regarding back pain is limited, it has been shown that individuals with chronic headaches report back pain more frequently.

In modern work environments, sedentary work and prolonged computer use are increasing. Prolonged sitting, improper ergonomics, and repetitive movements are considered significant risk factors for musculoskeletal problems. This can lead to pain and functional limitations, particularly in the neck, shoulders, and back. Although there has been an increase in working from home, especially after the pandemic, the time spent at a desk is still similar to that spent in the workplace. It is stated that static muscle activity and improper postures maintained during prolonged computer use can lead to increased strain on cervical and upper extremity muscles, exacerbating musculoskeletal symptoms. Literature reports that headaches and neck pain are common among individuals who work at desks; for example, a study of office workers reported that approximately 80% of individuals with headaches also experienced neck pain. Furthermore, high workload, time pressure, and psychosocial stress factors have been shown to be associated with both headaches and musculoskeletal pain in individuals who work at desks. Therefore, desk-based work conditions are considered a significant environmental factor that may play a role in the onset or exacerbation of migraine and musculoskeletal symptoms. Despite this, studies examining musculoskeletal symptoms, central sensitivity, and work stress together in desk-bound migraine patients are limited in the literature. Most studies have only examined individuals with headaches or evaluated musculoskeletal findings in limited areas. Therefore, studies comparing desk-bound migraine patients with non-migraine-bound desk-bound individuals could fill a significant gap in the literature. In this context, it is believed that the planned study will contribute to a better understanding of the possible relationships between migraine and musculoskeletal symptoms, help develop protective and rehabilitative approaches to the work environment, and benefit individuals exposed to musculoskeletal risks in desk-bound work, within the scope of Sustainable Development Goals 3: ensure healthy lives and promote well-being for all at all ages. The aim of this study is to compare central sensitization, work-related stress levels, and musculoskeletal symptoms in desk-based workers according to the presence of migraine and to examine the relationships among these variables.

03

Conditions studied

  • Migraine
  • Worker Health
  • Sensitization
  • Musculoskeletal Pain
  • Work Stress

Keywords

  • Migraine Disorders
  • Workplace
  • Musculoskeletal Pain
  • Rehabilitation
  • Sensitization
  • Worker Health
  • Sustainable Development Goals
  • Disability
  • SDG 3
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Gaziantep City Hospital, Department of Neurology, Gaziantep, Türkiye.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being between 18 and 65 years of age
  • Having been employed in an office job for at least 6 months
  • Working at a desk for at least 4 hours a day
  • Being able to read and understand Turkish
  • Agreeing to participate voluntarily
  • For individuals with a migraine diagnosis, having an episodic or chronic migraine diagnosis according to the International Classification of Headache Disorders Edition 3 criteria
  • For individuals without a migraine diagnosis, not having a diagnosis of migraine or other primary headache.

Exclusion criteria

Exclusion Criteria:

  • A history of neurological disorder (e.g., Multiple Sclerosis)
  • Inflammatory rheumatic disorders (e.g., Rheumatoid Arthritis)
  • Generalized chronic pain syndromes (e.g., Fibromyalgia)
  • Any other headache disease
  • Any other systemic disease
  • Acute fracture and infection
  • Neck or spinal surgery within the last 6 months
  • Serious musculoskeletal trauma within the last 6 months
  • Pregnancy
  • A cognitive or psychiatric condition that would prevent completion of the questionnaires
  • In the control group without a migraine diagnosis, a history of recurrent headaches within the last year.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
228 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Episodic migraine

    Episodic migraine is a neurological condition characterized by recurrent, moderate-to-severe headaches occurring on fewer than 15 days per month. Attacks typically last 4 to 72 hours and are often accompanied by nausea, vomiting, and light/sound sensitivity. Treatment involves acute, on-demand medication and preventative strategies to reduce attack frequency.

  • Chronic migraine

    Chronic migraine is defined by having 15 or more headache days per month for over three months, with at least eight of those days meeting migraine criteria. Symptoms include moderate-to-severe throbbing pain, nausea, vomiting, and extreme sensitivity to light, sound, or smell.

  • Control group without migraine diagnosis

    Individuals without a diagnosis of episodic or chronic migraine, as well as individuals without other headache diagnoses.

06

What researchers measure

Primary outcomes

  1. Central Sensitization Inventory

    The Central Sensitization Inventory (CSI) measures somatic and emotional symptoms common in central sensitization syndrome. Section A measures 25 symptoms with 5 response options (0 to 4). The total score ranges from 0 to 100. Section B asks patients whether they have previously been diagnosed with preliminary specific CSI conditions

    Time frame: Day 1

Secondary outcomes

  1. Headache Intensity

    The Numerical Pain Rating Scale (NPRS) consists of pain levels where the person indicates the pain they are currently experiencing with a vertical line on a plane. The pain felt by the person is given on a scale of 0-10, "0: no pain", "10: I feel very severe pain".

    Time frame: Day 1

  2. Disability

    The Migraine Disability Assessment (MIDAS) questionnaire evaluates the last 3 months of disability and consists of a 5-item self-administered test covering disability at work/school, household chores, family and social or leisure activities. The total number of days missed in these activities is the total score and classifies the disability as minimal disability (0-5 points), mild disability (6-10 points), moderate disability (11-20 points), or severe disability (≥21)

    Time frame: Day 1

  3. Work-Related Stress

    The General Work Stress Scale (GWSS) is a 9-item questionnaire that measures how much stress individuals experience in the workplace. It consists of 5 Likert-type items (Never=0, Rarely=1, Sometimes=2, Mostly=3, Always=4). Higher scores indicate increased workplace stress.

    Time frame: Day 1

  4. Musculoskeletal Pain Symptoms

    The Nordic Musculoskeletal Questionnaire (NMSQ) is a standardized, subjective data collection tool used to identify musculoskeletal disorders and pain in different areas of the body (low back, neck, shoulders, etc.). Individuals are asked whether they have experienced pain/discomfort in the relevant areas in the last 1 year or the last 7 days, usually coded as "Yes/No". The total number of painful areas is determined

    Time frame: Day 1

  5. Headache Impact

    The Headache Impact Test-6 (HIT-6) is a questionnaire for headaches that assesses vitality, pain, psychological distress, sociability, role, and cognitive functioning. Each item is scored on a 5-point Likert scale (6=never, 8=rarely, 10=sometimes, 11=very often, 13=always). The total score is determined by summing the scores on all six items and ranges from 36 to 78 points. (≤49 = little/no impact, 50-55 = some impact, 56-59 = significant impact, and 60-78 = serious impact).

    Time frame: Day 1

  6. Demographic and Clinic Evaluations

    Demographic and clinical information such as sex, age, weight, height, education level, occupation, medical history, family history, number of years diagnosed with migraine (if any), migraine triggers, symptoms experienced during attacks, number of headache days per month, number of headache attacks per month, duration of attacks, localization of headaches, and sitting time at a desk will be recorded for all patients.

    Time frame: Day 1

07

Study locations

1 site
  • Gaziantep City Hospital
    Gaziantep, Merkez, Turkey (Türkiye)
08

References and documents

Publications

  • Martelletti P, de Oliveira AB, Dhamija RK, Francis P, Gouider R, Guekht A, Al-Hasany AH, Houessou MA, Lanteri-Minet M, Leonardi M, Lu-Bolanos M, Pathirage M, Malik A, Mosaddeghi-Heris R, Netravathi M, Ojha R, Owolabi MO, Paudel R, Ray J, Raggi A, Ranta A, Rathnayake N, Reuter U, Sudibyo DA, Tanprawate S, Tao J, Tu Y, Tucker L, Vashchenko N, Waidyasekara J, Wang Y, Woldeamanuel YW, Wijeratne T. Migraine, headache disorders, and brain health: aligning advocacy with the UN Sustainable Development Goals. J Headache Pain. 2026 Apr 7;27(1):94. doi: 10.1186/s10194-026-02348-5. No abstract available. PubMed 41947032 ↗
  • Mohammadian M, Mollahoseini S, Naghibzadeh-Tahami A. Musculoskeletal disorders among office workers: prevalence, ergonomic risk factors, and their interrelationships. Sci Rep. 2025 Nov 26;15(1):45425. doi: 10.1038/s41598-025-30155-6. PubMed 41298697 ↗
  • Magnavita N. Headache in the Workplace: Analysis of Factors Influencing Headaches in Terms of Productivity and Health. Int J Environ Res Public Health. 2022 Mar 21;19(6):3712. doi: 10.3390/ijerph19063712. PubMed 35329399 ↗
  • Li C, Zhang L, Zhou J, Fan Z, Wang Y, Wang X, Wang W, Yu S. Prevalence of primary headache disorders among information technology staff in China: the negative effects of computer use and other correlative factors. BMC Public Health. 2020 Apr 5;20(1):443. doi: 10.1186/s12889-020-08497-9. PubMed 32248815 ↗
  • Cote P, van der Velde G, Cassidy JD, Carroll LJ, Hogg-Johnson S, Holm LW, Carragee EJ, Haldeman S, Nordin M, Hurwitz EL, Guzman J, Peloso PM; Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. The burden and determinants of neck pain in workers: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine (Phila Pa 1976). 2008 Feb 15;33(4 Suppl):S60-74. doi: 10.1097/BRS.0b013e3181643ee4. PubMed 18204402 ↗
  • Ernst MJ, Sax N, Meichtry A, Aegerter AM, Luomajoki H, Ludtke K, Gallina A, Falla D; NEXpro collaboration group. Cervical musculoskeletal impairments and pressure pain sensitivity in office workers with headache. Musculoskelet Sci Pract. 2023 Aug;66:102816. doi: 10.1016/j.msksp.2023.102816. Epub 2023 Jun 26. PubMed 37394322 ↗
  • Marchenko M, Domingues L, Barbero M, Cescon C, Falla D, Ernst MJ; NEXpro collaboration group. Headache, not neck pain, primarily influences the extent of pain in the neck region in symptomatic office workers. Cross-sectional and longitudinal evaluations. Physiother Theory Pract. 2026 May;42(5):689-699. doi: 10.1080/09593985.2025.2596179. Epub 2025 Dec 12. PubMed 41384674 ↗
  • Janwantanakul P, Pensri P, Jiamjarasrangsri V, Sinsongsook T. Prevalence of self-reported musculoskeletal symptoms among office workers. Occup Med (Lond). 2008 Sep;58(6):436-8. doi: 10.1093/occmed/kqn072. Epub 2008 Jun 10. PubMed 18544589 ↗
  • Lee S, DE Barros FC, DE Castro CSM, DE Oliveira Sato T. Effect of an ergonomic intervention involving workstation adjustments on musculoskeletal pain in office workers-a randomized controlled clinical trial. Ind Health. 2021 Mar 24;59(2):78-85. doi: 10.2486/indhealth.2020-0188. Epub 2020 Nov 28. PubMed 33250456 ↗
  • Darivemula SB, Goswami K, Gupta SK, Salve H, Singh U, Goswami AK. Work-related Neck Pain Among Desk Job Workers of Tertiary Care Hospital in New Delhi, India: Burden and Determinants. Indian J Community Med. 2016 Jan-Mar;41(1):50-4. doi: 10.4103/0970-0218.170967. PubMed 26917874 ↗
  • Hwang UJ, Han J, Kwon OY, Chu YS, Yang S. Classifying office workers with and without cervicogenic headache or neck and shoulder pain using posture-based deep learning models: a multicenter retrospective study. Front Pain Res (Lausanne). 2025 Jul 7;6:1614143. doi: 10.3389/fpain.2025.1614143. eCollection 2025. PubMed 40692757 ↗
  • Waersted M, Hanvold TN, Veiersted KB. Computer work and musculoskeletal disorders of the neck and upper extremity: a systematic review. BMC Musculoskelet Disord. 2010 Apr 29;11:79. doi: 10.1186/1471-2474-11-79. PubMed 20429925 ↗
  • Houle M, Ducas J, Lardon A, Descarreaux M, Marchand AA, Abboud J. Headache-related clinical features in teleworkers and their association with coping strategies during the COVID-19 pandemic. Front Public Health. 2023 Dec 28;11:1303394. doi: 10.3389/fpubh.2023.1303394. eCollection 2023. PubMed 38213645 ↗
  • Mayma-Aguirre KJ, Burgos-Flores MA, Sabastizagal-Vela IL, Astete-Cornejo JM. Working and health conditions in teleworkers in mandatory social isolation due to COVID-19: exploratory survey in Lima and Callao. Rev Bras Med Trab. 2024 Nov 14;22(3):e20231139. doi: 10.47626/1679-4435-2023-1139. eCollection 2024 Jul-Sep. PubMed 39606752 ↗
  • Alaca N, Acar AO, Ozturk S. Low back pain and sitting time, posture and behavior in office workers: A scoping review. J Back Musculoskelet Rehabil. 2025 Sep;38(5):919-943. doi: 10.1177/10538127251320320. Epub 2025 Mar 20. PubMed 40111906 ↗
  • Ashina S, Lipton RB, Bendtsen L, Hajiyeva N, Buse DC, Lyngberg AC, Jensen R. Increased pain sensitivity in migraine and tension-type headache coexistent with low back pain: A cross-sectional population study. Eur J Pain. 2018 May;22(5):904-914. doi: 10.1002/ejp.1176. Epub 2018 Jan 19. PubMed 29349847 ↗
  • Al-Khazali HM, Younis S, Al-Sayegh Z, Ashina S, Ashina M, Schytz HW. Prevalence of neck pain in migraine: A systematic review and meta-analysis. Cephalalgia. 2022 Jun;42(7):663-673. doi: 10.1177/03331024211068073. Epub 2022 Feb 15. PubMed 35166137 ↗
  • Matharu M, Katsarava Z, Buse DC, Sommer K, Reed ML, Fanning KM, Lipton RB. Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) cross-sectional study. Headache. 2024 Jul-Aug;64(7):750-763. doi: 10.1111/head.14753. Epub 2024 Jun 22. PubMed 38982663 ↗
  • Rees TA, Doukhi D, Wang VS, Balcerbula A, Bravo M, Fathi H, Holmuratova B, Kodounis M, Seyoum SA, Tasdelen S, Vekilyan H, Caronna E, Pozo-Rosich P. Neck pain in migraine: A narrative review and steps to correct evaluation and treatment. Cephalalgia. 2025 Oct;45(10):3331024251387449. doi: 10.1177/03331024251387449. Epub 2025 Oct 24. PubMed 41134815 ↗
  • de Tommaso M, Sciruicchio V. Migraine and Central Sensitization: Clinical Features, Main Comorbidities and Therapeutic Perspectives. Curr Rheumatol Rev. 2016;12(2):113-26. doi: 10.2174/1573397112666151231110813. PubMed 26717950 ↗
  • Dodick D, Silberstein S. Central sensitization theory of migraine: clinical implications. Headache. 2006 Nov;46 Suppl 4:S182-91. doi: 10.1111/j.1526-4610.2006.00602.x. PubMed 17078850 ↗
  • Aydinlar B, Bozkurt E, Senel A, Erdogan Soyukibar T, Acar E. Factors negatively affecting a migraine-friendly workplace in healthcare. Int J Occup Saf Ergon. 2026 Jun;32(2):572-578. doi: 10.1080/10803548.2025.2556615. Epub 2025 Sep 26. PubMed 41005315 ↗
  • Onan D, Yesildas PY, Akgor MC, Porsnok D. Central sensitization, work-related stress, and musculoskeletal pain symptoms in desk-based workers with and without migraine: a cross-sectional study. J Headache Pain. 2026 Jun 6;27(1):192. doi: 10.1186/s10194-026-02411-1. PubMed 42251278 ↗

Individual participant data

Plan to share: Undecided — The datasets used and/or analysed during the current study will be available from the corresponding author on reasonable request.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in May 2026, 0 months.

Of 132 non-industry observational studies under Migraine Disorders, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 72. This study's 0 months is below that.

Counting every sponsor, half of 160 studies reached it within 27 months; a quarter within 12 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 21, 2026
First posted
Apr 28, 2026
StartActual
Apr 23, 2026
Primary completionActual
May 1, 2026
CompletionActual
May 1, 2026
Last update
Oct 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 1, 2026
Primary completion
May 10, 2026→May 1, 2026 (actual)
Oct 1, 2026
Study completion
May 11, 2026→May 1, 2026 (actual)
Oct 1, 2026
Enrollment
159 (estimated)→228 (actual)
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    Recruiting→Completed
    Primary completion May 10, 2026→May 1, 2026 (now actual)
    Study completion May 11, 2026→May 1, 2026 (now actual)
    Enrollment 159 (estimated)→228 (actual)
    + 4 other changes: verification date, contact details, site details and references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07554664
Lead sponsor
Bozok University
Responsible party
Dilara Onan (Principal Investigator, Bozok University) — Principal investigator
First posted
Apr 28, 2026
Start date
Apr 23, 2026
Primary completion
May 1, 2026
Completion
May 1, 2026
Last update
Oct 1, 2026

Study contacts

Dilara Onan, PhD
principal investigator · Yozgat Bozok University
Merve Ceren Akgör, Neurologist
study chair · Department of Neurology, University of Health Sciences, Ankara Atatürk Sanatorium Training and Research Hospital, Ankara, Türkiye
Doğan Porsnok, PhD
study chair · Bingol University
Pelin Yenilmez Yeşildaş, Neurologist
study chair · Gaziantep City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion